Operator of a biotech company intended to facilitate the transition of discoveries from the laboratory to patients. The company creates a digital twin of cells to discover the right target and the right drug for the right patient and develop novel approaches based on state-of-the-art multi-omics data, machine learning and systems engineering to identify molecular triggers driving back a cell in its healthy state, enabling biotech and pharmaceutical companies to accelerate their target identification processes.